Clinical Trials Directory

Trials / Completed

CompletedNCT04079660

Glycemic Control Based on Serum Fructosamine Concentration vs. hemoglobinA1c (HbA1c) in Diabetic Patients

Prospective, Observational Study Evaluating the Glycemic Control Based on Serum Fructosamine Concentration vs. hemoglobinA1c (HbA1c) in Diabetic Patients Undergoing Surgeries

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Ohio State University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Diabetes mellitus is associated with negative outcomes in patients undergoing surgery. Blood sugar levels are monitored by measuring a values that include but are not limited to hemoglobin A1c, capillary blood glucose, and fructosamine . This study is being done to investigate if there is an associated between these values and postsurgical outcomes.

Detailed description

This study aims to compare the predictive capacity of both fructosamine and HbA1c on preoperative basal glucose level, as well as adverse events (cardiovascular events, surgical site infection, and mortality) and length of post-anesthesia care unit (PACU) stay in both Type I and Type II diabetic patients. Secondary outcomes include length of anesthesia administration, an indicator of intraoperative complications, and perioperative glucose level.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCapillary blood glucose blood drawCapillary blood glucose (CBG), HbA1c, fructosamine, albumin, BUN, and creatinine values will be obtained from a blood draw as a standard of care

Timeline

Start date
2021-02-01
Primary completion
2021-02-01
Completion
2021-02-01
First posted
2019-09-06
Last updated
2021-09-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04079660. Inclusion in this directory is not an endorsement.